NO20041785L - Farmasoytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt - Google Patents

Farmasoytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt

Info

Publication number
NO20041785L
NO20041785L NO20041785A NO20041785A NO20041785L NO 20041785 L NO20041785 L NO 20041785L NO 20041785 A NO20041785 A NO 20041785A NO 20041785 A NO20041785 A NO 20041785A NO 20041785 L NO20041785 L NO 20041785L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
mycophenolic acid
mycophenolate salt
mycophenolate
salt
Prior art date
Application number
NO20041785A
Other languages
English (en)
Other versions
NO341804B1 (no
Inventor
Juergen Dederichs
Thomas Rigassi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20041785(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20041785L publication Critical patent/NO20041785L/no
Publication of NO341804B1 publication Critical patent/NO341804B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20041785A 2001-10-17 2004-05-03 Fremgangsmåte for fremstilling av en farmasøytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt. NO341804B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds
PCT/EP2002/011589 WO2003032978A1 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt

Publications (2)

Publication Number Publication Date
NO20041785L true NO20041785L (no) 2004-05-03
NO341804B1 NO341804B1 (no) 2018-01-22

Family

ID=9924043

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041785A NO341804B1 (no) 2001-10-17 2004-05-03 Fremgangsmåte for fremstilling av en farmasøytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt.

Country Status (32)

Country Link
US (3) US20050013859A1 (no)
EP (1) EP1438040B2 (no)
JP (2) JP2005508959A (no)
KR (1) KR100671367B1 (no)
CN (1) CN1310640C (no)
AR (2) AR036813A1 (no)
AT (1) ATE374023T1 (no)
AU (1) AU2002338897B2 (no)
BR (1) BR0213355A (no)
CA (1) CA2460574A1 (no)
CO (1) CO5390076A1 (no)
CY (1) CY1107841T1 (no)
DE (1) DE60222687T3 (no)
DK (1) DK1438040T4 (no)
EC (2) ECSP024341A (no)
ES (1) ES2292819T5 (no)
GB (1) GB0124953D0 (no)
HK (1) HK1067861A1 (no)
HU (1) HU231114B1 (no)
IL (2) IL160968A0 (no)
MX (1) MXPA04003636A (no)
MY (1) MY139206A (no)
NO (1) NO341804B1 (no)
NZ (1) NZ532280A (no)
PE (1) PE20030476A1 (no)
PL (2) PL415001A1 (no)
PT (1) PT1438040E (no)
RU (2) RU2338528C2 (no)
SI (1) SI1438040T2 (no)
TW (1) TWI333861B (no)
WO (1) WO2003032978A1 (no)
ZA (1) ZA200401977B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
US20060069150A1 (en) * 2004-07-20 2006-03-30 Sandor Molnar Processes for preparation of crystalline mycophenolate sodium
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
EP1917010A2 (en) * 2005-02-08 2008-05-07 Aspreva Pharmaceuticals SA Compositions and methods for treating vascular, autoimmune and inflammatory diseases
US20060235009A1 (en) * 2005-02-08 2006-10-19 Richard Glickman Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
AU2006297130B2 (en) * 2005-09-30 2009-12-24 Novartis Ag DPP IV inhibitor for use in the treatment of autoimmune diseases and graft rejection
WO2007071580A1 (de) * 2005-12-21 2007-06-28 Basf Se Feinteiliges quervernetztes polyvinylpyrrolidon als tablettensprengmittel
WO2007093346A1 (en) * 2006-02-13 2007-08-23 Novartis Ag High dosage of mycophenolic acid (mpa)
ES2646112T3 (es) 2007-06-06 2017-12-12 Basf Se Formulación farmacéutica para la fabricación de comprimidos que se desintegran rápidamente
EP2164462B1 (de) 2007-06-06 2017-05-31 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
US9642808B2 (en) * 2007-08-13 2017-05-09 Panacea Biotech Limited Extended release compositions comprising mycophenolate sodium and processes thereof
EA201071035A1 (ru) * 2008-03-05 2011-04-29 Панацеа Биотек Лимитед Фармацевтические композиции модифицированного высвобождения, содержащие микофенолат, и способ их получения
WO2010004435A2 (en) * 2008-07-09 2010-01-14 Aspreva International Ltd. Formulations for treating eye disorders
EP2488173A1 (en) * 2009-10-13 2012-08-22 Teva Pharmaceutical Industries Ltd. Delayed release compositions
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
AU2018236225B2 (en) * 2017-03-13 2023-11-30 Okava Pharmaceuticals, Inc. Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
WO2019238647A1 (en) * 2018-06-14 2019-12-19 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
EP4284348A2 (en) * 2021-01-28 2023-12-06 Priothera SAS Methods of treatment with s1p receptor modulators
WO2022250977A1 (en) * 2021-05-26 2022-12-01 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
EP0670724A1 (en) * 1992-11-24 1995-09-13 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
CN1047075C (zh) * 1993-02-26 1999-12-08 普罗克特和甘保尔公司 比沙可啶剂型
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
RO115412B1 (ro) * 1993-10-01 2000-02-28 Syntex Inc Compozitie farmaceutica si procedeu de obtinere a compozitiei farmaceutice
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
AU4565000A (en) * 1999-05-10 2000-11-21 Novartis Ag Organic compounds
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
DE60023187D1 (de) * 2000-02-29 2006-02-23 Biocon Ltd Herstellung und reinigung von mycophenolsäure
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
RU2338528C2 (ru) 2008-11-20
ATE374023T1 (de) 2007-10-15
IL160968A0 (en) 2004-08-31
WO2003032978A1 (en) 2003-04-24
CN1310640C (zh) 2007-04-18
PL415001A1 (pl) 2016-02-29
GB0124953D0 (en) 2001-12-05
AR085778A2 (es) 2013-10-30
JP2005508959A (ja) 2005-04-07
MY139206A (en) 2009-08-28
PL234541B1 (pl) 2020-03-31
PT1438040E (pt) 2008-01-02
JP2009137996A (ja) 2009-06-25
PL367738A1 (en) 2005-03-07
DK1438040T3 (da) 2008-02-04
ES2292819T5 (es) 2020-05-29
MXPA04003636A (es) 2004-07-27
SI1438040T2 (sl) 2020-02-28
US20050013859A1 (en) 2005-01-20
DE60222687T2 (de) 2008-07-17
AU2002338897B2 (en) 2006-10-19
DE60222687D1 (de) 2007-11-08
US20100210717A1 (en) 2010-08-19
EP1438040B1 (en) 2007-09-26
DE60222687T3 (de) 2020-03-05
DK1438040T4 (da) 2020-01-27
PE20030476A1 (es) 2003-07-30
AR036813A1 (es) 2004-10-06
ES2292819T3 (es) 2008-03-16
RU2007130786A (ru) 2009-02-20
KR20050037409A (ko) 2005-04-21
HUP0600451A2 (en) 2006-09-28
CO5390076A1 (es) 2004-04-30
EP1438040B2 (en) 2019-10-16
CA2460574A1 (en) 2003-04-24
IL160968A (en) 2016-04-21
HU231114B1 (hu) 2020-09-28
NO341804B1 (no) 2018-01-22
EP1438040A1 (en) 2004-07-21
ZA200401977B (en) 2006-05-31
SI1438040T1 (sl) 2008-04-30
CY1107841T1 (el) 2013-06-19
RU2381026C2 (ru) 2010-02-10
RU2004115332A (ru) 2005-04-20
BR0213355A (pt) 2006-05-23
US20120237601A1 (en) 2012-09-20
NZ532280A (en) 2007-05-31
TWI333861B (en) 2010-12-01
ECSP024342A (es) 2003-03-10
HK1067861A1 (en) 2005-04-22
KR100671367B1 (ko) 2007-01-19
ECSP024341A (es) 2003-12-01
CN1564684A (zh) 2005-01-12

Similar Documents

Publication Publication Date Title
NO20041785L (no) Farmasoytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
FI20011478A (fi) Farmaseuttinen koostumus
MA26937A1 (fr) Nouvelle composition pharmaceutique.
NO20033384D0 (no) Farmasöytisk formulering
DK1448195T3 (da) N-adamantylmethylderivater og mellemprodukter som farmaceutiske præparater og fremgangsmåde til fremstilling deraf
DK1395242T3 (da) Flydende farmaceutisk sammensætning
NO20033785D0 (no) Farmasöytisk formulering
IS7051A (is) Lyfjasamsetningar
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
FI20011889A0 (fi) Menetelmä ksylitolin valmistamiseksi
FI20022128A (fi) Farmaseuttinen koostumus
NO20042502L (no) Farmasoytisk formulering omfattende bicalutamid
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
DE60108483D1 (de) Gelenkwelle
NO20033073L (no) Farmasöytisk sammensetning inneholdende citalopram
DK1429753T3 (da) Farmaceutisk sammensætning omfattende gamma-butyrobetain
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
FI20011204A0 (fi) Peräsinrakenne
DE60042203D1 (de) Emulsionszusammensetzungen vom typ oel-in-wasser
ITRM20010579A1 (it) Composizione farmaceutica naturale contro la varroasi.
DK1289514T3 (da) Anvendelse af substituerede 1-amino-5-phenylpentan-3-ol- og/eller 1-amino-6-phenylhexan-3-ol-forbindelser som lægemidler
FI5468U1 (fi) Farmaseuttinen koostumus
DK200100203U4 (da) Farmaceutisk komposition indeholdende citalopram

Legal Events

Date Code Title Description
MK1K Patent expired